Alkermes (ALKS) Other Non Operating Income (2010 - 2026)
Alkermes (ALKS) posted quarterly Other Non Operating Income of $352000.0 for Q2 2026, down 54.35% year-over-year from $771000.0 in Q2 2025, and up 127.22% quarter-over-quarter from -$1.3 million in Q1 2026.
Alkermes (ALKS) Other Non Operating Income (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Other Non Operating Income for 17 consecutive years, with $352000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Other Non Operating Income fell 54.35% year-over-year to $352000.0; the TTM figure through Jun 2026 stood at $3.7 million (down 56.07% YoY), while the FY2025 annual figure was $7.0 million, down 16.44% from the prior year.
- Other Non Operating Income advanced to $352000.0 in Q2 2026 per ALKS's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Other Non Operating Income topped out at $6.4 million in Q4 2023 and bottomed at -$1.9 million in Q3 2022.
- Historically, Other Non Operating Income has averaged $1.4 million across 5 years, with a median of $664500.0 in 2024.
- On a YoY basis, Other Non Operating Income climbed as much as 915.32% in 2022 and fell as far as 746.18% in 2022.
- Alkermes' Other Non Operating Income stood at $2.0 million in 2022, then soared by 224.05% to $6.4 million in 2023, then declined by 12.86% to $5.6 million in 2024, then fell by 11.27% to $4.9 million in 2025, then sank by 92.86% to $352000.0 in 2026.
- Business Quant data shows ALKS's Other Non Operating Income at $352000.0 in Q2 2026, -$1.3 million in Q1 2026, and $4.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 352,000.00 |
| Mar 31, 2026 | -1.29 Mn |
| Dec 31, 2025 | 4.93 Mn |
| Sep 30, 2025 | -280,000.00 |
| Jun 30, 2025 | 771,000.00 |
| Mar 31, 2025 | 1.56 Mn |
| Dec 31, 2024 | 5.55 Mn |
| Sep 30, 2024 | 558,000.00 |
| Jun 30, 2024 | 2.05 Mn |
| Mar 31, 2024 | 182,000.00 |
| Dec 31, 2023 | 6.37 Mn |
| Sep 30, 2023 | 149,000.00 |
| Jun 30, 2023 | -525,000.00 |
| Mar 31, 2023 | -39,000.00 |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | -1.86 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 2.43 Mn |
| Dec 31, 2021 | 8.04 Mn |
| Sep 30, 2021 | 288,000.00 |